ATAlexander Tarakhovsky

Alexander Tarakhovsky

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Alexander Tarakhovsky has a total of 12 co-authors. Here are the top co-authors by number of shared publications:

  • Gemma Texido

    Department of Immunology, Institute for Genetics, University of Köln, D-50931 Cologne, Germany

    2 shared publications
  • I-Hsin Su

    School of Biological Sciences, College of Science, Nanyang Technological University, Republic of Singapore

    2 shared publications
  • Ingrid Mecklenbräuker

    Department of Immunology1 and Laboratory of Lymphocyte Signaling,2 Institute for Genetics, University of Köln, D-50931 Cologne, Germany, and Department of Molecular Biology and Genetics, Howard Hughes Medical Institute, The Johns Hopkins University School of Medicine, Baltimore, Maryland 212053

    2 shared publications
  • Klaus Rajewsky

    Program in Cellular and Molecular Medicine, Children’s Hospital, and Immune Disease Institute, Harvard Medical School, Boston, USA

    2 shared publications
  • Clifford A. Lowell

    From the *Department of Laboratory Medicine, University of California, San Francisco, California 94143; ‡Laboratory of Lymphocyte Signaling and §Department of Immunology, Institute for Genetics, University of Köln, Weyertal 121, D-50931 Köln, Germany; ‖Max-Planck-Institut für Immunbiologie, Stubeweg 51, D-79108 Freiburg, Germany; and ¶Department of Immunology, Saga Medical School, Nabeshima, Saga 849, Japan

    1 shared publication
  • Kaoru Saijo

    Department of Immunology1 and Laboratory of Lymphocyte Signaling,2 Institute for Genetics, University of Köln, D-50931 Cologne, Germany, and Department of Molecular Biology and Genetics, Howard Hughes Medical Institute, The Johns Hopkins University School of Medicine, Baltimore, Maryland 212053

    1 shared publication

Latest Publications

  • The B-Cell-Specific src-Family Kinase Blk Is Dispensable for B-Cell Development and Activation

    by Gemma Texido, I-Hsin Su, Ingrid Mecklenbräuker, Kaoru Saijo, Sami N. Malek, Stephen Desiderio, Klaus Rajewsky, Alexander Tarakhovsky

    The B-cell lymphocyte kinase (Blk) is a src-family protein tyrosine kinase specifically expressed in B-lineage cells of mice. The early onset of Blk expression during B-cell development in the bone marrow and the high expression levels of Blk in mature B cells suggest a possible important role of Blk in B-cell physiology. To study the in vivo function of Blk, mice homozygous for the targeted disruption of the blk gene were generated. In homozygous mutant mice, neither blk mRNA nor Blk protein is expressed. Despite the absence of Blk, the development, in vitro activation, and humoral immune responses of B cells to T-cell-dependent and -independent antigens are unaltered. These data are consistent with functional redundancy of Blk in B-cell development and immune responses.


  • Open Access

    The Molecular Mechanism of B Cell Activation by toll-like Receptor Protein RP-105

    by Vivien W.F. Chan, Ingrid Mecklenbräuker, I-Hsin Su, Gemma Texido, Michael Leitges, Rita Carsetti, Clifford A. Lowell, Klaus Rajewsky, Kensuke Miyake, Alexander Tarakhovsky

    The B cell–specific transmembrane protein RP-105 belongs to the family of Drosophila toll-like proteins which are likely to trigger innate immune responses in mice and man. Here we demonstrate that the Src-family protein tyrosine kinase Lyn, protein kinase C β I/II (PKCβI/II), and Erk2-specific mitogen-activated protein (MAP) kinase kinase (MEK) are essential and probably functionally connected elements of the RP-105–mediated signaling cascade in B cells. We also find that negative regulation of RP-105–mediated activation of MAP kinases by membrane immunoglobulin may account for the phenomenon of antigen receptor–mediated arrest of RP-105–mediated B cell proliferation.